illinoi
littl patienc offer timing-driven cut
earli stage psr leav lot room improv
new york mellon corp bk
mix clear posit tp increas
model tweak revis ebitda bridg manag catch
preview better clariti
catch sdc reiter outperform
solid quarter book forward look includ meaning roe improv
reli macro capit clariti
frame expect initi phase data tripl meet
feedback meet manag
search green shoot stock appear discount high degre
go three-peat mantl ridg unload half stake
softwar growth momentum continu
strengthen fortress amidst competit intrus
potenti strong year target big order
expect solid continu invest sfn river system
credibl path ep growth year
state cro industri stabl environ look biotech fund
print
public contain summari recent credit suiss research report bring notabl research attent full report summari
certif legal entiti disclosur inform statu non-u analyst equiti research disclosur click
connect client corpor highlight calgari connect
focu tri-specif catalyst
infrastructur insight preliminari preview focus frac thought
expect solid quarter driven continu execut believ
opportun upsid light recent downturn investor sentiment nbi
under-perform ytd vs ytd driven larg part declin
end end view investor remain concern drug price especi
elect growth broader macroeconom issu howev believ
continu commerci clinic execut could contribut upsid evid
fundament strength could improv investor sentiment toward recal
beat across board revenu ep weve seen recent fundament chang
industri suggest soft beyond season compani specif legal overhang
mostli resolv except on-going challeng biogen tecfidera ip
decis ipr challeng expect
discuss view sector go earn host call
increas posit sector somewhat off-set increas
regulatori scrutini acquisit array allergan otezla alder help
enhanc investor sentiment continu support valuat howev allergan
receiv second request ftc rais concern biotech come
increas regulatori scrutini recal bristol/celgen subject second request lead
delay closur transact ultim result divestitur otezla overal
believ limit data point support conclus face greater regulatori
hurdl note smaller continu happen healthi pace
vertex neurocrin well pois ahead quarter vertex project higher ep
con con rev cs vs continu believ
guidanc conserv beatabl neurocrin could beat ingrezza rev cs
though note ingrezza sale seen histor soft due
season beat may provid tougher qoq comparison
quarter could mix consensu expect
revenu cs vs con ep vs weve seen sign
resili base busi led enbrel may off-set under-perform repatha
neulasta increas due advanc pipelin season
could face challeng quarter project lower revenu
compar consensu seen evid zolgensma use
sma recal report weaker spinraza sale weak could continu
new incid patient receiv zolgensma might previous start spinraza
load phase spinraza first year make expens year treatment patient
receiv dose drug eros incid market could lower averag revenu per
patient time
weve made chang target price estim detail herein
date product utc date dissemin utc
base intra-year statutori financi disclosur recal much person auto/hom industri
serv non-publ mutual insur person line profit continu hover
level long-term histor averag impli cushion insur
keep near term price level low despit headwind low interest rate increas
within note look histor soft-market price cycl conclud
price unlik turn near term stock multipl vs
histor average alreadi discount margin/profit deterior fear
expect ultim outperform call work auto price level need begin rise
current flattish level earli order ep estim maintain
reduc target price given potenti sustain current weaker price
environ continu indic rise loss cost reduc tp
ntm ep estim risk includ continu slow price growth loss cost
price month
date product utc date dissemin utc
gener expect earn line consensu across coverag univers
could see volatil commerci name includ
like name coverag univers like
price volatil quarter share fairli larg swing prior commerci
updat name far yield greatest inbound interest far respect
result estim arikayc sale vs consensu howev believ actual
revenu number vs consensu overshadow disclosur number new start
metric durabl treatment would construct stabl patient add
new start evid solid durat treatment possibl
commentari look could touch topic like percentag arikayce-tr patient
continu treatment beyond month degre payer restrict relat reauthor
beyond month non-cultur convert percentag patient cultur
convertw think commerci practic convers rate may exceed rate observ
trial manag road last month felt seem confid
unit three manufactur receiv approv gener
remodulin expect investor focu remain focus trajectori loss share
uthr parenter treprostinil franchis think upsid street number possibl
on-going litig sandoz/raregen see impact gener player
well may provid upsid sc remodulin brand persist meanwhil found sign
clear payer pressur brand remodulin earli day gener
non-commerci compani earn gener unev non-commerci
compani compani commonli use call opportun refresh investor
stori provid updat pipelin develop guid believ
follow could event earn disclos new clinic result
mavacamten non-obstruct hcm data nohcm preview
dmd gene therapi high dose data
obsv nolasiban ivf result nolasiban preview
alna reloxalias result preview
model chang part note introduc new model/valu methodolog
part lower target price separ lower
tp
date product utc date dissemin utc
illinoi
price month
sell-off legal concern well-overdon illinoi week
announc util ceo ann pramaggior suddenli retir past tens
emphas ratchet on-going concern potenti impact feder investig
illinoi hous speaker michael madigan sever member state legislatur
interact financi deal lobbyist departur follow second
subpoena investig last week search warrant serv illinoi senat june
item includ relat exelon offici issu support
busi individu includ limit rate increas howev even
appli discount possibl elimin formula rate hb
pend reauthor probabl loss illinoi zec reduc
tp land still solid outperform rate especi drop month
nevertheless recal broad support total depend
futur energi job act establish nuclear subsidi commission oliva note
naruc summer polici confer also note appoint bg ceo
calvin butler interim util ceo solid choic given compani success bg
roe oper like elimin interim statu yearend
expect in-lin vs consensu guidanc major
driver includ favor weather off-set lower nuclear gener ttm project
dont expect chang current guidanc cs/consensu
although lower half rang appear like
valuat estim unchang pjm power market recoveri
rel modest vs steep declin tp reduc
higher peer electr price-to-earnings off-set applic discount illinoi
util earn versu zero previous anoth probabl loss
illinoi nuclear zec subsidi discount npv risk
includ regulatori legisl capital-expenditure execut commod price oper merchant
date product utc date dissemin utc
price month
littl patienc offer timing-driven
event report revenu vs street ebit vs
street ep vs street driven tax management narrow ep guidanc
cut guidanc vs prior
invest thesi continu disappoint fundament three three quarter
year come street revenu core ebit exclud one-tim gains/loss
quarter result also coincid cut guidanc pension
contribut driven expect higher ye aviat inventori
plan longitud deliveri slip next year mostli time relat longitud delay
also appear margin implic next year due requir labor-intens
modif associ certif though midpoint ep guidanc
maintain larg result lower tax vs prior impli
fundament incom statement guidanc drop mostli lower revenu margin
expect textron aviat model margin vs initi guidanc
think guid mostli de-risk point see less rel downsid go
though arguabl risk given high hurdl said improv
nice next year work capit trend improv ultim win either armi two
activ futur vertic lift program next down-select fara expect march would
game changer bell materi long-term posit share
acknowledg remain cheap ev/ebitda trade cse qualiti
asset end market prevent us see materi upsid reiter neutral
estim valuat reduc ebitda estim ep estim
revis lower tax model mainten valu use
sotp ev/ebitda valuat methodolog blend ev/ebitda multipl
result target price vs prior target price declin driven lower ebitda
estim well lower assign multipl textron aviat system industri
higher assign multipl bell multipl adjust driven chang peer
multipl risk includ lower global growth weaker bizjet market competit
date product utc date dissemin utc
even result trade reduc ep target also
introduc new target essenti target delay one year
expect cut target believ impli ep compound-annual-growth-rate may
prove optimist interest rate continu declin emb rate cut and/or price
pressur continu industri expect pfof shelf fee cash sweep advisori fee
also believ etf shelf-fe could declin etf trade commiss cut level
play field etf sponsor longer need pay rev-shar commission-fre platform
reduc ep lower ep estim
made minor adjust net interest incom fee servic charg
assumpt tp remain includ probability-weight
independ ep bullish scenario driven merger
shelf-fe etfc organ growth remain lower peer
remain attract asset view lack brokerag scale
fidel industri lead corpor servic busi
gener strong organ growth valuabl cross-sel opp ms acquir
competitor solium also found corpor servic busi attract also estim
signific expens overlap e-brok competitor could also provid
new sourc distribut larger bank asset manag mani broker-asset manag
combo bank-own asset manag gain market share last five year
includ fidel vanguard
date product utc date dissemin utc
price month
earli stage psr leav lot room
earli inning psr unp result miss expect continu like long
term setup oper metric servic level improv acceler pace
network becom resili fact took mani head show
compani capabl adjust quickli even sharp chang biz level
someth seen histor jim vena note compani still earli
stage drive effici gain give us confid substanti runway
 improv next coupl year visibl carload growth
remain limit given macro uncertainti believ compani well posit
gener outsiz oper leverag return growth stage specif longer train
fluid network increas workforc product support unp abil captur
volum higher increment margin demand return maintain outperform
lower estim rais tp ep forecast fall
estim decreas dcf-deriv
tp rise lower discount rate share count off-set lower base year
ebit risk tp macro decreas fluiditi
network chang continu roll op stat improv continu
ration network recent close kansa citi hump yard shift classif work
major yard compani reduc touch point remov work event seen
acceler improv servic level kpi car trip plan complianc loco
product workforc product freight car veloc train length also
increas sinc januari move mix manifest train
biz vs hist norm give increas flexibl run longer
train well opportun move traffic previous fit within custom
train schedul ration appear far complet although jim vena told
investor stay tune chang announc due cours think know
exactli chang want make ultim want take network
date product utc date dissemin utc
price month
new york mellon corp bk
mix clear posit tp
increas
bni mellon report ep better estimate/consensu revenu
right line forecast aggreg basi expens came lower term revenu
composit servic fee forecast growtha clear positiveevid
number busi line look forward think best emb cost lower interest
rate assum letup competit secular pressur also think fair assum
benefit market valu appreci new busi traction expense/capit
manag latter could prove point conservat materi increas capac
buyback assum cet becom bind constraint final scb/new ccar
consid third quarter upsid busi trend interest rate outlook
expect net benefit item sale promontori net restructur charg forecast
benefit ep increas basi estim
estim unchang increas free capit gener take target
price risk achiev estim target price tie
level short term interest rate market valu net asset flow competit landscap
highlight posit momentum mani servic busi
long time come custodi asset qtr/qtr servic fee forecast ii letup
focu expens control iii expect after-tax gain sale promontori
alon ought increas capit return capac ccar cycl cet end
quarter standard basi forecast year end rel
requir minimum estim new ccar
date product utc date dissemin utc
price month
price month
model tweak revis ebitda bridg
model updat updat model modest shift raw materi flow follow
catch call compani manag today alumina lag smelter estimate month
delay cost becancour estim achiev run-rat capac end
strong increment margin note estimate becancour ran annual
rate ebitda loss lower power cost lme link deal account
major smelter product month lag
revis ebitda bridg lower revis lower annual ebitda bridg
account lower smelter save incorrectli appli total ton versu ton produc
incorpor metric us roll brazil hydro calcul spot lme
alumina price aa would gener ebitda versu prior bridg
note forecast ebitda assum alumina lme
product gain evid poor oper perform earli
benefit capit invest new manag mainten spend
expect alumina segment convers cost trend lower expect product
remain strong level roll mill under-perform owe oper issu
impact smelter margin tie warrick mill
strong asset return limit cash pension opeb fund
see low degre growth capital-expenditure restructur cash outflow total
spain becancour improv union agreement becancour posit
smelter solid contributor go forward aa
raw materi updat pitch final come cs estim tailwind
caustic stabil aa buy mix us gulf ne asia calcin coke move
lower spot ytd averag
valuat estim chang ebitda prior reflect
slight delay cost tailwind sotp base tp remain risk chines suppli
growth global aluminum demand trend pension
date product utc date dissemin utc
strengthen fortress amidst
price month
remain attract growth stori view reduct long-term outlook last
week warrant amidst on-going challeng like better fear global retail
sale growth unit growth us compstore intern compstore still among
best restaur togeth disciplin cost manag drive double-digit
ep growth despit competit headwind expect us compstore least stabil
lower increment competit headwind easier compstore aggress near-term
initi improv sentiment
breadth depth third-parti deliveri weigh compstore base geospati analysi
dpz us store base compet restaur aggreg platform
nearli dpz store base compet least
restaur dpz store base rel diversifi believ
urban store repres outsiz impact compstore given higher auv like face
greatest pressur howev given alreadi signific aggreg presenc across store
base believ benefit less increment competit intrus go forward
expect focu enhanc competit advantag within deliveri segment
improv execut given less advantag conveni offer deliveri
near-term focu recent address opportun aggress
respond competit headwind includ effort around market deliveri insur carryout
featur five crust digital-onli late night new menu innov
technolog enhanc track smart make-lin tool carryout also bright
spot posit carryout traffic offset weak deliveri compris nearli
order sale
estim chang lower ep ep
larg driven conserv compstore expect
on-going competit headwind
valuat target price base ntm ebitda month
ntm ep month
date product utc date dissemin utc
potenti strong year target
big order
volatil day trade open initi reaction neg ep
guidanc revis neg interpret ep framework revis later clarifi
call stock grind higher close vs follow
confer call focus big order opportun prioriti
delev balanc sheet see potenti base base busi ni
convers almost big net inventori less capital-expenditure
help delev achiev leverag mid-year
order strong momentum order contribut record backlog
organ increas y/i highlight includ order greater
segment equal share india highlight new region growth
partner local oper expand citi ga network develop also
strong start receipt order caribbean power plant project
deploy focus de-lever leverag declin sequenti chart
priorit debt reduct plan reach
guidanc lower sale guidanc lower
driven time order almost entir impact sale fy ep
rang lower also larg driven time chart expect base
time chart provid visibl project chart
note time chang extend big cycl total revenu big
expect expect big order
price month
valuat risk tp unchang repres ep
equat ev/ebitda multipl yield ep
estim given recent macro risk includ slowdown global energy-
relat capital-expenditure spend project slippag equip substitut c-driven asian
date product utc date dissemin utc
expect solid continu invest
sfn river system
remain outperform shopifi head result given numer driver
posit shop sustain revenu growth long-term includ secular shift
e-commerce shopifi shopifi fulfil network anticip
aforement trend posit impact top-line result guidanc though expect
continu invest growth area
revenu anticip upsid subscript solut merchant solut
revenu magnitud beat like line prior quarter average beat
subscript merchant solut upsid subscript revenu particularli
platform fee like driven shopifi adopt
continu perform well accord check
expens expect top line perform drive oper incom out-performance though
note street model adjust acquisit river system
non-gaap expens impact street current model non-gaap
oper incom vs post-acquisit guidanc continu
invest launch shopifi fulfil network
fulfil look addit commentari surround earli access program plan
river system insight price and/or roll-out dont expect fulfil
impact merchant growth gmv continu expect benefit sfn
long run
upu univers postal union recent reach deal reform fee structur threat
us leav union new agreement us abl impos self-
declar rate start juli year period phase new fee new
agreement could impact busi current dropship via epacket believ shopifi
exposur fairli low singl digit gmv slightli higher impact mrr
phase period could help mitig exposur would still expect continu demand
product current ship via epacket despit futur increas ship cost
date product utc date dissemin utc
credibl path ep growth year
credibl path ep growth year see credibl path ep
growth inclus share repurchas think hon out-performance
today driven lower-than-norm expect print still solid quarter
demonstr power diversifi portfolio aerospac benefit abil
drive execut better sp margin perform despit lower sale think still
enough uncertainti world self-help lever outperform understand
stock perform risk associ risk-on day also believ multipl
cap today signific re-rat alreadi happen tsr larg driven ep
dividend growth
price month
strength long-cycl honeywel deliv oper beat organ
sale omx ex-spin vs vs guid strength led
long-cycl aero organ sale long-cycl backlog y/i sp organ sale
declin driven short-cycl product solut off-set cost action
remain strong growth expect mark year strongest
china sale msd order dd
free capac adjust repres convers
manag see opportun improv work capit share repo total
bring ytd total vs prior guidanc see excess
balanc sheet capac deploy share repo repres ep growth
 pipelin remain activ market condit potenti drive asset price
valuat risk target price unchang base ep
estim equat premium vs year
averag in-lin tp impli yield risk includ broaden short
cycl weak valuat impact non-cash pension incom supplier pressur ba/ab
softwar competit
date product utc date dissemin utc
price month
tent agreement place gm uaw get better sens
strike cost gm unsurprisingli concess higher origin
offer month ago pre-strik wage base increas increment less
flexibl nevertheless earli read concess dont significantli alter financi
profil await ratif highlight primari concess provid
perspect prior comment strike see address key uaw gm
near long-term impact gm
wage increas contract provid wage increas second fourth year
contract lump sum first third year contract context gm
spend annual hourli us labor includ benefit higher wage impli
structur higher cost alongsid combin lump sum payment
thu amid forecast gm earn na ebit year higher wage dont
radic chang pictur final refer origin pre-strik propos gm offer
wage lump sum increas four year
ratif payment full-tim employe receiv ratif bonu temp
worker receiv bonu all-in like impli ratif payment
convers offer pre-strik ratif bonu would impli
payment agreement would assum ratif payment thu
increment payment doesnt chang financi pictur gm
capac situat larg unchang importantli gm part agreement gm
go forward plan shutter three four us plant previous dealloc
product fourth plant detroit hamtramck get electr truck within next four year
gm offer pre-strik moreov deal includ shift vehicl current
built mexico back us plant someth union sought crucial point gm
help gm address capac util
date product utc date dissemin utc
preview better clariti
anticip report in-lin better quarter strong guidanc driven win
popul alert continu traction cem addit close acquisit
lead guidanc ahead expect prior guidanc includ minim
contribut deal
result expect top-line result roughli line magnitud beat
past year top line beat perform driven continu strong public
sector wins/renew across countri state citi bill expect quarter
reason last quarter lap acquisit um street bill expect
y/i compar impli year bill stack vs
expect ttm bill vs last quarter
guidanc anticip upsid guidanc driven momentum busi
sign sinc quarter close includ contract state california closur
acquisit guidanc provid earn noisi includ minim
revenu contribut much expens base bake anticip
contribut revenu depend write-down impact purchas
base recent financi impli purchas price revenu
financi profil mid-to-high singl digit revenu growth mid-to-high
teen oper margin pleasantli surpris posit oper margins/
ebitda/fcf especi investor focu sustain growth improv profit
acquisit margin accret anticip impact defer revenu write-
though like minim deal revenu growth dilut anticip top-lin
synergi cross sell opportun acceler core growth
date product utc date dissemin utc
catch sdc reiter outperform
insight sdc gener counsel sdc share fell monday follow news
governor california sign california assembl reaction view
overdon particularli given share deterior to-dat base discuss today
sdc gener counsel bill requir radiographi equival bone imag prior
orthodont treatment languag bill remain ambigu presum allow
treat doctor determin constitut suffici imag forese sdc
modifi oper ca argu itero scanner impress kit system fulfil
state requir junctur moreov teledentistry-rel legisl go
effect board given stakehold opportun submit public comment
promulg regul still await estim ca repres total store
case volum
proactiv regulatori front sdc face backlash sever state
profession organ georgia alabama new jersey tennesse sdc continu
defend practic effect ftc doj demonstr support sdc
countersuit alabama georgia feder organ file amicu brief
state sdc take increasingli proactiv approach creat legisl
build relationship support favor dynam across broader telehealth arena
testament effort sdc recent experienc posit resolut iowa idaho
reiter outperform sdc share deterior sinc septemb ipo vs
 flat technic dynam concern quarterli volatil regulatori risk
view share deterior egregi share current trade ev/
sale larger stand-alone competitor broader peer group
despit superior growth profil sdc remain highli lever rapidli expand
larg underserv dtc market market penetr driven expand
smileshop footprint innov smilepay financ geograph expans view
support top-lin growth inher margin leverag thereon turn profit
clear align bull/bear lunchon pleas reach relev sale
repres schedul follow-up call
date product utc date dissemin utc
price month
initi view trade result in-lin
ep report core ep exclud loan loss provis benefit
in-lin estim consensu lower
ep target given commiss cut initi releas target
net new asset in-lin nna in-lin forecast higher
last quarter
posit balanc sheet nim trend etfc on-bal sheet cash deposit increas
q/q despit balanc sheet reposit program held
parti bank increas nim stronger estim
q/q aid sell lower yield secur previou quarter
strong buy-back activ quarter repurchas stock came
estim
revenu higher revenu came estim driven
higher core revenu interest incom commiss fee servic charg better
expens also estim drove adjust oper result in-lin
forecast
dart roughli in-lin dart roughli in-lin estim street
flat q/q commiss per trade improv q/q
came estim commiss per trade declin significantli given
recent commiss cut zero stock etf option analysi dart less
date product utc date dissemin utc
solid quarter book forward look
reli macro capit clariti
earlier morn report third quarter earn per share nice
reduc expect cs consensu upsid revenu oper leverag
driven lower tax rate benefit result per share rel forecast
per share discret tax benefit quarter roe target rang
rote target rang solidli within bank target rang even
cet next healthi invest bank pipelin oper leverage/
expens disciplin ought support achiev forward expect factor
upsid rais basi estim estim
unchang target price unchang valu weigh dcf
model capit retent -- imagin upsid world ccar process
disproportion punit capit market busi risk relat estimates/target
price tie health capit market evolut capit requir
fundament highlight invest bank ficc revenu well ahead
forecast healthi pipelin support forward look solid posit net asset inflow
wealth manag pre-tax marginw expect manag lift
target rang januari consist confid growth prospect higher margin
return earn increment dollar brought onto ms platform lowlight worth
note sequenti quarter increas risk weight asset like tie strength
dcm fix incom trade
date product utc date dissemin utc
price month
frame expect initi phase data
tripl meet feedback
meet manag
mirati manag meet frame expect tripl meet emphasi
earli natur clinic data today met chri lemast chief busi
offic mirati compani offic san diego get deeper perspect expect
aacr-nci-eortc tripl meet boston note mr lemast
blind clinic data abl help better frame expect meet
discuss long-term strategi program includ compani view ration
combin next step beyond tripl meet left meet
nuanc expect term data disclosur get hint addit
